Robert Auciaux's most recent trade in Usana Health Sciences Inc was a trade of 10,630 Deferred Stock Units done . Disclosure was reported to the exchange on May 9, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Usana Health Sciences Inc | Robert Auciaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2022 | 10,630 | 0 | - | - | Deferred Stock Units | |
| Usana Health Sciences Inc | Robert Auciaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2022 | 10,630 | 11,284 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Robert Auciaux | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.59 per share. | 09 May 2022 | 3,192 | 8,092 (0%) | 0% | 74.6 | 238,091 | Common Stock |
| Usana Health Sciences Inc | Robert Auciaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2022 | 312 | 748 (0%) | 0% | 0 | Common Stock | |
| Usana Health Sciences Inc | Robert Auciaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2022 | 312 | 0 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Robert Auciaux | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.93 per share. | 25 Apr 2022 | 94 | 654 (0%) | 0% | 75.9 | 7,137 | Common Stock |
| Usana Health Sciences Inc | Robert Auciaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2022 | 312 | 312 | - | - | Restricted Stock Unit | |
| Usana Health Sciences Inc | Robert Auciaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2022 | 312 | 530 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Robert Auciaux | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.29 per share. | 09 Feb 2022 | 94 | 436 (0%) | 0% | 85.3 | 8,017 | Common Stock |
| Usana Health Sciences Inc | Robert Auciaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2021 | 312 | 624 | - | - | Restricted Stock Unit | |
| Usana Health Sciences Inc | Robert Auciaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2021 | 312 | 828 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Robert Auciaux | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.48 per share. | 27 Oct 2021 | 94 | 734 (0%) | 0% | 99.5 | 9,351 | Common Stock |
| Usana Health Sciences Inc | Robert Auciaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2021 | 312 | 936 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Robert Auciaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2021 | 312 | 610 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Robert Auciaux | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.83 per share. | 28 Jul 2021 | 94 | 516 (0%) | 0% | 99.8 | 9,384 | Common Stock |
| Usana Health Sciences Inc | Robert Auciaux | Director | Sale of securities on an exchange or to another person at price $ 101.72 per share. | 17 Jun 2021 | 596 | 298 (0%) | 0% | 101.7 | 60,625 | Common Stock |
| Usana Health Sciences Inc | Robert Auciaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2021 | 1,248 | 1,674 | - | - | Restricted Stock Unit | |
| Usana Health Sciences Inc | Robert Auciaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2021 | 426 | 1,248 | - | - | Restricted Stock Unit | |
| Usana Health Sciences Inc | Robert Auciaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2021 | 426 | 1,022 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Robert Auciaux | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.80 per share. | 26 Apr 2021 | 128 | 894 (0%) | 0% | 88.8 | 11,366 | Common Stock |